Gene · 5167
Papers3,183
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,183
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tanshinone IIA&Icaritin -MPs regulated vascular normalization and restored tumor-infiltrating T lymphocyte function to boost anti-PD-1 therapy in melanoma lung metastasis. | J Nanobiotechnology | 2026 | 41593707 | PubTator, text mining | PubMed |
| A DNA-based nanodevice senses purinergic signaling and drives an immune switch for resolving inflammation. | Nat Commun | 2026 | 41588001 | PubTator, text mining | PubMed |
| RoboA reinforces planarian stem cell fate through FoxA and Anosmin1a. | Nat Commun | 2026 | 41577713 | PubTator, text mining | PubMed |
| Free-floating long-term vascularized mesenchymal organoids. | iScience | 2026 | 41568151 | PubTator, text mining | PubMed |
| Burosumab in Unidentifiable Tumor-Induced Osteomalacia. | Clin Case Rep | 2026 | 41567527 | PubTator, text mining | PubMed |
| In silico design of a multi-epitope vaccine targeting DENV-1 and DENV-3. | Sci Rep | 2026 | 41545417 | PubTator, text mining | PubMed |
| Enzyme-regulated biomineralization: Biological functions and advanced biomaterials for tissue regeneration. | Bioact Mater | 2026 | 41541281 | PubTator, text mining | PubMed |
| FOXM1 regulates platelet-induced anoikis resistance in pancreatic cancer cells. | Cell Commun Signal | 2026 | 41535944 | PubTator, text mining | PubMed |
| Chamber-specific chromatin architecture guides functional interpretation of disease-associated Cis-regulatory elements in human cardiomyocytes. | Nat Commun | 2026 | 41526351 | PubTator, text mining | PubMed |
| REACT-PXE: a consensus on diagnosis and future research concerning pseudoxanthoma elasticum (PXE). | Ann Dermatol Venereol | 2026 | 41519013 | PubTator, text mining | PubMed |
| Interaction between ENPP1 and homologous recombination deficiency defines distinct pan-cancer signatures: A retrospective observational study. | Medicine (Baltimore) | 2026 | 41496120 | PubTator, text mining | PubMed |
| Identification of genetic factors regulating anther size in wheat under heat stress environment. | BMC Plant Biol | 2026 | 41491428 | PubTator, text mining | PubMed |
| From molecular design to immune remodeling: Advances in perylene diimide-based multimodal cancer therapies. | Eur J Med Chem | 2026 | 41483508 | PubTator, text mining | PubMed |
| Distinct plasma inflammatory signatures reflect disease severity and progression in progressive supranuclear palsy: a prospective cohort study. | J Neural Transm (Vienna) | 2026 | 41460330 | PubTator, text mining | PubMed |
| Soft-Drug-Inspired MnSTF Nano-Adjuvant for Safe and Synergistic cGAS-STING Activation in Tumor Immunotherapy. | Adv Sci (Weinh) | 2026 | 41400033 | PubTator, text mining | PubMed |
| Lipid Metabolism Alterations in Hereditary Inorganic Pyrophosphate Deficiency Syndromes: A Narrative Review of Insights and Controversies. | J Inherit Metab Dis | 2026 | 41376271 | PubTator, text mining | PubMed |
The prevalence of ENPP1 deficiency in humans with Ossification of the Posterior Longitudinal Ligament and the preclinical efficacy of ENPP1 enzyme therapy in murine Ossification of the Posterior Longitudinal Ligament. | J Bone Miner Res | 2026 | 41251406 | PubTator, text mining | PubMed |
| Autosomal recessive hypophosphatemic rickets type 2 (ARHR2): Is phosphate supplementation safe? | Bone | 2026 | 41176198 | PubTator, text mining | PubMed |
| The IUPHAR/BPS Guide to PHARMACOLOGY in 2026. | Nucleic Acids Res | 2026 | 41160876 | PubTator, text mining | PubMed |
| Enpp1 inhibition: a promising oral therapy for later-onset hypophosphatasia. | J Bone Miner Res | 2026 | 41128771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5167/papers?page=5